DR.NUELL VANISHING BB- glycerin, adenosine cream

Land: USA

Språk: engelsk

Kilde: NLM (National Library of Medicine)

Kjøp det nå

Last ned Preparatomtale (SPC)
10-11-2019

Aktiv ingrediens:

GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX), ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567)

Tilgjengelig fra:

Apharm Co., Ltd.

Administreringsrute:

TOPICAL

Resept typen:

OTC DRUG

Indikasjoner:

brightening wrinkle improvement UV protection use BB cream alone, or take the appropriate amount and apply it evenly along with the skin texture in the last stage of skin care

Autorisasjon status:

OTC monograph not final

Preparatomtale

                                DR.NUELL VANISHING BB- GLYCERIN, ADENOSINE CREAM
APHARM CO., LTD.
_Disclaimer: Most OTC drugs are not reviewed and approved by FDA,
however they may be marketed if they_
_comply with applicable regulations and policies. FDA has not
evaluated whether this product complies._
----------
arbutin, adenosine, ethylhexyl methoxycinnamate, titanium dioxide
brightening
wrinkle improvement
UV protection
Keep out of reach of children
use BB cream alone, or take the appropriate amount and apply it evenly
along with the skin texture in the
last stage of skin care
1) if there is any abnormal symptom or side effect, such as red spot,
swelling and itching when using
cosmetlcs or after using due to direct sunlight, consult
dermatologists
2) Do not use for wounded areas
3) Precautions for storage and handling
keep out of reach of children, store away from direct sunlight
4) avoid the eye area
water, cyclopentasiloxane, dimethicone, etc.
For external use only
Apharm Co., Ltd.
DR.NUELL VANISHING BB
glycerin, adenosine cream
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN OTC DRUG
ITE M CODE (SOURCE )
NDC:73430 -0 0 0 7
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
GLYCERIN (UNII: PDC6 A3C0 OX) (GLYCERIN - UNII:PDC6 A3C0 OX)
GLYCERIN
7 g in 10 0 mL
ADENO SINE (UNII: K72T3FS56 7) (ADENOSINE - UNII:K72T3FS56 7)
ADENOSINE
0 .0 4 g in 10 0 mL
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
PRO PANEDIO L (UNII: 59 6 5N8 W8 5T)
BUTYLENE GLYCO L (UNII: 3XUS8 5K0 RA)
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:73430 -0 0 0 7-1
30 mL in 1 TUBE; Type 0 : No t a Co mbinatio n Pro duct
11/0 1/20 19
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
OTC mo no graph no t final
pa rt347
11/0 1/20 19
LABELER -
Apharm Co., Ltd. (689054266)
REGISTRANT -
Apharm Co., Ltd. (689054266)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
APHARM Co ., Ltd.
6 8 9 0 5426 6
ma nu
                                
                                Les hele dokumentet
                                
                            

Søk varsler relatert til dette produktet